DSKA

Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals - 05/14 - 11:03 AM ET

Duska to file NDA for antiarrhythmic drug - 04/28 - 09:35 AM ET

DSKA: Meeting w/FDA re 505(b)(2) NDA for ATPace(TM) - 04/25 - 08:43 AM ET

Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) - 04/25 - 08:00 AM ET

Duska Therapeutics Plans 505(b) (2) NDA Filing Route for ATPace(TM) - 04/25 - 06:12 AM ET

Professor Riccardo Polosa Joins Duska Therapeutics' Scientific Advisory Board - 04/02 - 10:50 AM ET

Duska Therapeutics Plans Meeting with the FDA on ATPace - 03/11 - 08:43 AM ET

RedChip TV Interviews CEO of Duska Therapeutics, Inc. - 02/25 - 08:29 AM ET

Duska Therapeutics to Present At Winter Global Equities Conference - 02/20 - 09:00 AM ET

Duska Therapeutics Completes Corporate Office Relocation to La Jolla - 01/29 - 01:05 PM ET

RedChip Announces Duska Therapeutics CEO Television Interview Available Online - 11/13 - 01:10 PM ET

RedChip Radio: Exclusive Interview With Duska Therapeutics - 11/02 - 12:00 PM ET

Duska Therapeutics, Inc. Announces Engagement of RedChip Companies, Inc. to Lead Public and Investor Relations - 11/01 - 09:28 AM ET

DSKA: Appoints Shepard Goldberg and Steven Dinh to the BoD - 10/18 - 08:56 AM ET

Duska Therapeutics Inc elects H. David Coherd to board - 10/12 - 04:45 AM ET

DSKA: Appoints H. David Coher to the BoD - 10/11 - 08:33 AM ET

Duska Therapeutics Appoints H. David Coherd to the Board of Directors - 10/11 - 08:30 AM ET

Duska Therapeutics Completes $5.75 Million Private Equity Financing - 10/01 - 04:14 PM ET

<< Back to Stock Index